D-156-2013 Class III Terminated
FDA drug recall D-156-2013 was initiated by Bayer HealthCare Pharmaceuticals Inc. on May 31, 2012 and is designated Class III. Reason for recall: Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point. The recall status is terminated (terminated May 10, 2013). Affected quantity: 138,505 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 13, 2013
- Initiation Date
- May 31, 2012
- Termination Date
- May 10, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 138,505 vials
Product description
Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2
Reason for recall
Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.
Distribution pattern
Nationwide
Code information
B18511 Exp. 04/12 , B18513 Exp. 05/12, B18515 Exp. 06/12, B18517 Exp. 06/12, B18825 Exp. 10/12, B18831 Exp.12/12
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-156-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026